Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid in Non-alcoholic Fatty Liver Disease
NCT04475276Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alpha-lipoic acid in non-alcoholic fatty liver disease (NAFLD), sponsored by AIIMS New Delhi. Started Feb 2021; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT04475276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475276.